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Abstract. 
 
Oncoprotein 18 (Op18, also termed p19, 
19K, metablastin, stathmin, and prosolin) is a recently 
identified regulator of microtubule (MT) dynamics. 
Op18 is a target for both cell cycle and cell surface re-
ceptor-coupled kinase systems, and phosphorylation of 
Op18 on specific combinations of sites has been shown 
to switch off its MT-destabilizing activity. Here we 
show that induced expression of the catalytic subunit of 
cAMP-dependent protein kinase (PKA) results in a 
dramatic increase in cellular MT polymer content con-
comitant with phosphorylation and partial degradation 
of Op18. That PKA may regulate the MT system by 
downregulation of Op18 activity was evaluated by a ge-
netic system allowing conditional co-expression of 
PKA and a series of kinase target site–deficient mu-
tants of Op18. The results show that phosphorylation of 
Op18 on two specific sites, Ser-16 and Ser-63, is neces-
sary and sufficient for PKA to switch off Op18 activity 
in intact cells. The regulatory importance of dual phos-
phorylation on Ser-16 and Ser-63 of Op18 was repro-
duced by in vitro assays. These results suggest a simple 
model where PKA phosphorylation downregulates the 
MT-destabilizing activity of Op18, which in turn pro-
motes increased tubulin polymerization. Hence, the 
present study shows that Op18 has the potential to reg-
ulate the MT system in response to external signals 
such as cAMP-linked agonists.
 
M
 
icrotubules 
 
(MTs)
 
1
 
 are important for many
cellular processes, for example in organelle
transport, organizing the cytoplasm, and for in-
tracellular movement of cell surface receptors (for review
see Cole and Lippincott-Schwartz, 1995). During cell divi-
sion, large arrays of MTs form the mitotic spindle, which
segregates condensed chromosomes (for review see Hy-
man and Karsenti, 1996). The remarkable dynamic behav-
ior of MTs, termed “dynamic instability,” can be described
as stochastic transitions at MT ends between phases of
growth and shrinkage, with transitions from shrinking to
growing called “rescues,” and the reverse called “catastro-
phes” (for review see Desai and Mitchison, 1997).
The multitude of cellular functions involving MTs and
their dynamic behavior makes regulation of MT assembly
a central cell biological issue. Little is known, however,
about regulation of MT dynamics in response to external
and internal cellular signals. Most studies on this topic
have been concerned with microtubule-associated pro-
teins (MAPs), a group of proteins that regulate MT dy-
namics by direct binding (for review see Mandelkow and
Mandelkow, 1995). Many reports have described how phos-
phorylation of MAPs by various protein kinases, including
the cAMP-dependent protein kinase (PKA), decreases
their MT-binding activities. However, the significance of
these findings for regulation of MT dynamics in intact cells
remains to be established (for review see Maccioni and Cam-
biazo, 1995).
Studies on intact cells indicate the presence of MT-regu-
latory factors that oppose the MT-stabilizing activity of
MAPs by promoting catastrophes and thereby increasing
the dynamics of MTs (for review see McNally, 1996). Two
such factors that increase the catastrophe rate have re-
cently been identified, namely a kinesin-like protein,
XKCM1 (Walczak et al., 1996) and a cytosolic protein, on-
coprotein 18 (Op18; Belmont and Mitchison, 1996). Op18
has been given many names in the literature (e.g., p19,
19K, metablastin, prosolin, and stathmin) due to its com-
plex pattern of phosphorylation and its elevated expres-
sion in a variety of human malignancies (for review see
Belmont et al., 1996). By using a conditional expression
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system and kinase target site–deficient mutants of Op18,
we have previously demonstrated that Op18 is a phosphor-
ylation-responsive regulator of MT dynamics in intact
cells; and furthermore, that multisite phosphorylation dur-
ing mitosis downregulates the MT-destabilizing activity of
Op18 (Marklund et al., 1996). These findings were ex-
tended in a subsequent study, where it was shown that mi-
tosis-specific phosphoisomers of Op18 have severely re-
duced in vitro activities toward purified tubulin (Larsson
et al., 1997). Taken together, the combined genetic, bio-
chemical, and morphological data indicates that downreg-
ulation of Op18 activity is essential for formation of the
mitotic spindle.
Studies in brain tissue and various cell lines have shown
that Op18 is phosphorylated on four residues, namely Ser-
16, Ser-25, Ser-38, and Ser-63 (Labdon et al., 1992; Beretta
et al., 1993; Marklund et al., 1993
 
a
 
; Wang et al., 1993). All
four phosphorylation sites are subject to regulation by ex-
ternal signals during the cell cycle. During mitosis, Op18 is
phosphorylated on all four sites to high stoichiometry;
Ser-25 and Ser-38 are phosphorylated by members of the
cyclin-dependent kinase family, and Ser-16 and Ser-63 by
an as yet unidentified protein kinase (Brattsand et al., 1994;
Larsson et al., 1995). Op18 is also phosphorylated by sev-
eral kinase systems in response to external signals. Thus,
Op18 is phosphorylated on Ser-25 by members of the mi-
togen-activated protein (MAP) kinase family in response
to phorbol esters, T cell antigen receptor stimulation, and
nerve growth factor (Beretta et al., 1993; Marklund et al.,
1993
 
a
 
,
 
b
 
). Op18 is also phosphorylated by Ca
 
2
 
1
 
/calmodu-
lin-dependent kinase IV/Gr (CaMK IV/Gr) on Ser-16 in
response to calcium signals in specific cells that express this
kinase (Marklund et al., 1993
 
a
 
; Melander Gradin et al., 1997).
Finally, cAMP-linked agonists have been shown to in-
crease Op18 phosphorylation (Schubart et al., 1987), and
subsequent studies have shown PKA-mediated in vitro
phosphorylation of Op18 on both Ser-16 and Ser-63 (Ber-
etta et al., 1993).
As outlined above, recent studies have shown that phos-
phorylation-mediated downregulation of Op18 activity is
essential in human cell lines during formation of the mi-
totic spindle. These results imply that Op18 activity is of
primary importance in regulating MT dynamics during the
interphase of the cell cycle, and not during mitosis. It fol-
lows that kinase systems regulated by external signals, such
as MAP kinase, PKA, and CaMK IV/Gr, may have impor-
tant functions in regulating the MT-destabilizing activity
of Op18. We have recently addressed this question by study-
ing the consequences of CaMK IV/Gr-mediated phosphor-
ylation of Op18. This study demonstrated that CaMK IV/
Gr-mediated phosphorylation of Ser-16 suppresses Op18
activity in intact cells (Melander Gradin et al., 1997). How-
ever, the data did not exclude regulatory importance of
constitutive phosphorylation on additional sites of Op18.
Importance of additional sites appears likely, because sub-
sequent in vitro studies in our laboratory have suggested
that phosphorylation on multiple sites of Op18 synergize
in downregulation of Op18 activity. PKA has the potential
to phosphorylate two specific sites of Op18 and may, there-
fore, be a very efficient regulator of Op18 activity and con-
sequently also of the MT system. The present study ad-
dresses this possibility by evaluating the MT-regulatory
 
role of all four potential phosphorylation sites of Op18 in
response to PKA activity.
 
Materials and Methods
 
DNA Constructs and Transfections
 
The coding region of a cDNA encoding a c-myc epitope–tagged C
 
a
 
 sub-
unit of PKA (NcoI to ApaI fragment; Orellana and McKnight, 1992), was
cloned into pMEP4 (Groger et al., 1989) as a BamHI to HindIII fragment
after linking to the 5
 
9
 
 untranslated region of Op18. The pMEP4-based
Op18 derivatives and 
 
D
 
CaMK IV/Gr used in this study has been described
together with standard and co-transfection protocols for the K562 leuke-
mia cell line (Marklund et al., 1994; Larsson et al., 1995; Melander Gradin
et al., 1997). The pMEP4 shuttle vector contains the Epstein-Barr virus
origin of replication and the 
 
EBNA-1
 
 gene to allow high-copy episomal
replication, and the 
 
hph
 
 gene, which confers hygromycin B resistance in
mammalian cells (Groger et al., 1989). Conditional expression of various
Op18 derivatives was achieved by using the hMTIIa promoter, which can
be suppressed by low concentrations of EDTA (50 
 
m
 
M) and induced by
Cd
 
2
 
1
 
 (0.03–0.2 
 
m
 
M; Marklund et al., 1994). Transfected cells were cul-
tured in a medium containing EDTA (50 
 
m
 
M) that has been specifically
designed to support cell growth under conditions that minimize expres-
sion from the hMTIIa promoter (Marklund et al., 1994). About 50–70%
of all pMEP4-transfected cells surviving electroporation were resistant to
hygromycin B (0.25 mg/ml; Boehringer Mannheim, Mannheim, Germany)
and mock-transfected cells were killed within 3 d. Experiments were rou-
tinely performed 5–6 d after transfection.
 
Analysis of MT Polymerization Status, Op18 
Phosphoisomers, SDS-PAGE, and Western Blot
 
Preparation of total cellular proteins and separation of proteins by 10–
20% gradient SDS-PAGE has been described (Marklund et al., 1994). The
cellular content of MT polymers was determined by extracting soluble tu-
bulin in an MT-stabilizing buffer followed by quantification of tubulin in
the particulate and soluble fraction as described (Minotti et al., 1991; Mark-
lund et al., 1996). Affinity-purified anti-Op18, specific for the COOH-termi-
nal (anti-Op18:34–149) or NH
 
2
 
-terminal (anti-Op18:2–33), was prepared
and used for Western blot analysis as described (Brattsand et al., 1993).
For detection of epitope-tagged proteins, an anti–c-myc antibody (AB-1,
Oncogene Science Inc., Manhasset, NY) or the anti–Flag-M2 antibody
(Kodak) was used. 
 
125
 
I-protein A or the enhanced chemiluminescence de-
tection system (Amersham Buchler GmbH, Braunschweig, Germany),
were used to reveal bound antibodies, as indicated. PhosphorImager anal-
ysis of radioactive bands was used for quantification. As a control for
equal loading, the relevant part of filters was routinely probed with rabbit
anti–triose-phosphate isomerase (Brattsand et al., 1993). To analyze Op18
phosphoisomers, we used a native PAGE system that separates Op18 ac-
cording to the charge differences introduced by each of the four identified
phosphorylations (Marklund et al., 1993
 
b
 
).
 
In Vitro Phosphorylation of Op18, Cross-linking
of Op18–Tubulin Complexes and Determination of
the MT-destabilizing Activity of Op18
 
Wild-type (wt) and kinase target site–deficient mutant derivatives of puri-
fied 
 
Escherichia coli
 
–derived Op18 were prepared as described (Brattsand
et al., 1993). Purified Op18 was in vitro phosphorylated to high stoichiom-
etry with PKA (New England BioLabs, Inc., Beverly, MA) by incubating
2.8 U of kinase/
 
m
 
g of Op18 in 50 mM Tris-HCl, pH 7.5, 10 mM MgCl
 
2
 
 and
500 
 
m
 
M ATP for 3 h at 30
 
8
 
C. Reactions were terminated by heating to
75
 
8
 
C for 10 min and precipitated overnight at 
 
2
 
20
 
8
 
C with 6 vol of MeOH
containing 1% sucrose. The precipitate was washed twice with 75% MeOH
containing 1% sucrose, dried under vacuum, and resuspended in PEM
buffer (80 mM Pipes, 1 mM EDTA, 1 mM Mg
 
2
 
1
 
, pH 6.8). To remove
PKA that remained insoluble after MeOH precipitation, the final prepa-
ration of phosphorylated Op18 was clarified by centrifugation (15 min,
14,000 
 
g
 
). The concentration of the resulting phosphorylated Op18 was
calculated using SDS-PAGE comparison with a standard recombinant
Op18 preparation. As controls, in vitro phosphorylations were also per-
formed either in the absence of ATP or by using mutants of Op18 lacking
the specific phosphorylation sites. In these cases, tubulin binding and MT- 
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destabilizing activity of Op18 was unaffected. Therefore, the observed ef-
fects of Op18 phosphorylation could be attributed to addition of phos-
phate groups to specific Ser residues. Purified bovine tubulin was ob-
tained from Cytoskeleton (Denver, Colorado). For cross-linking studies,
Op18 (1 
 
m
 
M) and tubulin (10 
 
m
 
M) was incubated in 30 
 
m
 
l of PEM buffer
with 1 mM GTP. After 120 min on ice, 6 
 
m
 
l of glutaraldehyde (0.3%) was
added and the sample was incubated at 18
 
8
 
C. The reaction was quenched at
various times by addition of 1 vol 2-mercaptoethanol (10%)/glycine (0.2 M),
precipitated in 66% acetone, and the cross-linked Op18-tubulin com-
plexes analyzed by SDS-PAGE. In vitro assembly of tubulin (4 
 
m
 
M) in the
presence of various amounts of Op18 was performed in assembly buffer
(25 
 
m
 
l of PEM buffer with 1 mM GTP, containing an additional 4 mM
Mg
 
2
 
1
 
, 10% glycerol and 4 
 
m
 
g/ml taxol) as previously described (Larsson
et al., 1997). Determination of tubulin and Op18 protein mass, by analysis
of amino acid composition, was performed as described (Brattsand et al.,
1993).
 
Immunofluorescence and Flow Cytometric Analysis
 
Cells were extracted with MT-stabilizing buffer (see above) containing
0.05% saponin and 10 
 
m
 
g/ml RNase. Cells were fixed in 4% paraformalde-
hyde and 0.5% glutaraldehyde for 15 min followed by quenching with
NaBH
 
4
 
, and thereafter stained with anti–
 
a
 
-tubulin (clone B-5-1-2, Sigma
Chemical Co., Poole, UK). Bound antibodies were revealed by fluores-
cein conjugated rabbit anti–mouse Ig and DNA was stained with 0.1 
 
m
 
g/
ml propidium iodide. Cells were mounted using 1 mg/ml of 
 
p
 
-phenylendi-
amine in PBS with 80% glycerol and analyzed by epifluorescence. MT flu-
orescence was also analyzed by flow cytometry as described (Roos et al.,
1993).
 
Results
 
Regulation of MT Polymerization Status by Ectopic 
Expression of Op18, CaMK IV/Gr, and PKA
 
To investigate MT-regulatory properties of Op18 and two of
its cognate protein kinases, we expressed epitope-tagged
derivatives of Op18-wt, a constitutively active mutant of
CaMK IV/GR (
 
D
 
CaMK IV/Gr), and the catalytic C
 
a
 
 sub-
unit of PKA in K562 leukemia cells using the Cd
 
2
 
1
 
-induc-
ible pMEP4 shuttle vector system. Western blot analysis of
lysates from transfected cells reveals induced expression
of the indicated gene products within 4 h of Cd
 
2
 
1
 
 addition
(Fig. 1 
 
A
 
, note that the band migrating below endogenous
Op18 is caused by proteolysis). Quantification of data from
several experiments shows that Cd
 
2
 
1
 
 treatment results in
5–20-fold induction of Op18 and 30–100-fold induction of
 
D
 
CaMK IV/Gr and PKA.
Previous studies have shown that CaMK IV/Gr phos-
phorylates Op18 on a single site, namely Ser-16, both in
vitro and in intact cells. Previous in vitro experiments have
shown that PKA phosphorylates Op18 on two sites, namely
Ser-16 and Ser-63. To analyze Op18 phosphoisomer com-
position in cells induced to express either 
 
D
 
CaMK IV/Gr
or PKA, we used a native gel system (Marklund et al.,
1993
 
b
 
). The data shows, in agreement with a previous re-
port (Melander Gradin et al., 1997), that essentially all en-
dogenous Op18 molecules are phosphorylated on a single
site in cells induced to express 
 
D
 
CaMK IV/Gr (Fig. 1 
 
B
 
).
In agreement with the site preference of PKA in vitro (Be-
retta et al., 1993), it is also shown that overexpression of
this kinase results in phosphorylation of two sites of Op18.
We have recently shown that overexpression of Op18
causes destabilization of interphase MTs and that this ac-
tivity of Op18 can be suppressed by phosphorylation (Mark-
lund et al., 1996; Melander Gradin et al., 1997). The re-
sponse to ectopic Op18 expression, or two of its cognate
Figure 1. (A) Regulated expression of PKA, DCaMK IV/Gr, and
Op18 from the hMTIIa-promoter. K562 cells were transfected
with the indicated pMEP4 constructs (see text) and “stable”
transfectants were selected by cultivation with hygromycin and
EDTA for 5 d as described in Materials and Methods. Expression
from the hMTIIa-promoter was either suppressed with EDTA or
induced as indicated with Cd21 (0.03 and 0.2 mM) for 4 h. Cell ly-
sates were resolved by SDS-PAGE, proteins transferred to nitro-
cellulose filter, and ectopic expression of c-myc epitope–tagged
catalytic subunit of PKA and Flag epitope–tagged DCaMK IV/Gr
was detected with the appropriate epitope-tag specific mouse
monoclonal antibody and rabbit anti–mouse Ig. To visualize both
endogenous Op18 and Flag epitope–tagged Op18, rabbit anti-
Op18:2–33 was used. Bound antibodies were revealed by 125I-pro-
tein A. (B) K562 cells expressing the indicated pMEP4 constructs
were induced with Cd21 (0.2 mM) for 4 h. Op18 was partially pu-
rified from cell lysates and resolved by native PAGE. After trans-
fer to nitrocellulose filter, Op18 phosphoisomers were detected
by rabbit anti-Op18. The arrows indicate the migration of non-
phosphorylated Op18, as well as migration forms of Op18 with
various numbers of phosphate groups (1-P, 2-P, 3-P, and 4-P).
The assignment of the arrows is based on the migration of recom-
binant Op18 with defined number of phosphorylated sites. (C)
Cellular content of MT polymers was analyzed in K562 cells
transfected with the indicated pMEP4 constructs. Expression
from the hMTIIa-promoter was regulated as described for A. 
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kinases, on the level of cellular content of MT polymers is
shown in Fig. 1 
 
C.
 
 In agreement with our previous reports,
ectopic expression of Op18 results in depolymerization of
MTs, whereas expression of 
 
D
 
CaMK IV/Gr results in in-
creased MT polymers. Most importantly, it is also shown
that expression of PKA increased cellular content of MT
polymers with even higher efficiency than 
 
D
 
CaMK IV/Gr.
Induced expression of 
 
D
 
CaMK IV/Gr has been shown
to result in a partial (
 
z
 
50%) degradation of endogenous
Op18. Both the phosphorylation of Op18 on Ser-16 and
the associated partial degradation of Op18 are likely to
contribute to the observed increase of cellular content of
MT polymers in response to 
 
D
 
CaMK IV/Gr expression
(Melander Gradin et al., 1997). Fig. 2 shows the time course
of Cd
 
2
 
1
 
-induced PKA expression and the consequences of
induced expression on endogenous Op18 protein levels
and cellular content of MT polymers. The data reveal that
similarly to 
 
D
 
CaMK IV/Gr, PKA-mediated phosphoryla-
tion induces a partial degradation of Op18. Moreover, it is
also evident that the cellular content of MT polymers in-
creases in parallel with Op18 degradation. Cd
 
2
 
1
 
 induces a
10-fold increase of PKA expression within 2 h. At this
early time point, both downregulation of Op18 and in-
creased MT polymers are readily observed.
 
PKA-mediated Phosphorylation Switches Off the
MT-destabilizing Activity of Op18
 
To dissect the function of PKA-specific Op18 phosphory-
lation at distinct sites, we used a previously described co-
transfection protocol (Melander Gradin et al., 1997). This
protocol allows regulated expression of two co-transfected
gene products and efficient phosphorylation of ectopic
Op18 by a cognate protein kinase. It is shown by Western
blot analysis in Fig. 3 
 
A
 
 that PKA can be efficiently co-
expressed with either Op18-wt or Op18-S16,63A. In agree-
ment with the data in Fig. 1 
 
A
 
, levels of endogenous Op18
are decreased after induced expression of PKA alone (note
that phosphorylation results in a minor shift in migration).
However, in contrast to the endogenous Op18, we do not
detect a significant decrease in the levels of ectopic Op18
protein because of rapid-induced expression during the
time course of the experiment. Hence, the present co-trans-
fection protocol is useful to explore the effect of specific
regulatory phosphorylations of Op18 on the MT-regulatory
activity of Op18, with minimal interference on the level of
protein degradation.
To determine if PKA phosphorylation regulates Op18
activity, we analyzed alterations in cellular content of MT
polymers in co-transfected cells. As expected, Cd
 
2
 
1
 
 treat-
ment of cells transfected with vector-Co alone was without
effect, whereas co-transfection of vector-Co with either
Op18-wt or Op18-S16,63A results in Cd
 
2
 
1
 
-induced depo-
lymerization of MTs (Fig. 3 
 
B
 
). Moreover, as predicted from
the data shown above, co-transfection of vector-Co and
PKA results in a Cd
 
2
 
1
 
-induced increase in MT polymers.
Most significantly, co-transfected PKA completely sup-
presses the MT-depolymerizing activity of Op18-wt, but not
of the Op18-S16,63A PKA target site–deficient mutant.
The simplest interpretation of the results outlined above
is that PKA-mediated phosphorylation of Ser-16/Ser-63
switches off the MT-regulatory function(s) of Op18. How-
ever, the overexpressed and PKA phosphorylated Op18
protein may have some aberrant MT-regulatory properties
that are not detected by analysis of total cellular content of
MT polymers. Therefore, we analyzed the appearance of
MTs in co-transfected cells by immunofluorescence. The
analysis was performed on cells extracted with an MT-sta-
bilizing buffer before fixation, and nuclear DNA was
stained with propidium iodide. The immunofluorescence
shown in Fig. 4 
 
A
 
 demonstrates a characteristic interphase
network of MTs in cells induced to express PKA either
alone or together with Op18-wt. Moreover, cells induced
to express any of the two Op18 derivatives without PKA,
or Op18-S16,63A together with PKA, contained very few
MTs. The spherical shape of the K562 leukemia cells used
in this study is not optimal for morphological studies of
MTs and it is not possible to analyze the length or number
of individual MTs. Nevertheless, detailed examination of
cells using high magnifications failed to reveal any mor-
phological differences in the MT network displayed in
cells expressing PKA alone or together with Op18-wt.
To quantify MT-specific immunofluorescence and to an-
alyze heterogeneity within the cell population, we used flow
cytometry. The resulting histograms show that expression
of PKA alone results in a 1.8-fold homogeneous increase
in mean fluorescence of the major cell population (Fig. 4 
 
B
 
,
note log scale). It is also shown that induced expression of
Op18 results in an almost 10-fold decrease in MT specific
fluorescence. Most significantly, PKA restores the fluores-
cence in cells co-transfected with Op18-wt, but not Op18-
S16,63A.
Taken together, the result in Fig. 4 suggests that PKA
Figure 2. Time course of induced PKA expression increased cel-
lular content of MT polymers and partial degradation of endoge-
nous Op18. K562 cells were transfected with a pMEP4 derivative
directing expression of the catalytic subunit of PKA, and drug-
resistant cells were selected as in Fig. 1. Cells were thereafter in-
duced with Cd21 (0.2 mM) for the indicated period and total cel-
lular proteins were resolved by SDS-PAGE. Ectopic expression
of the protein kinase (m), the levels of endogenous Op18 protein
(j) and cellular content of MT polymers (d), were quantified by
Western blot using specific antibodies and 125I-protein A as de-
scribed under Materials and Methods. The Op18 content in non-
induced cells was arbitrarily set to 100%. Calculation of Op18
content was internally controlled by probing the relevant part of
the Western blot filter with anti–triose-phosphate isomerase,
which does not vary under the experimental conditions used. The
presented data is representative for three independent experi-
ments. 
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expression induces a homogeneous increase of cellular
content of MT polymers without gross alterations in MT
morphology. Moreover, cells overexpressing Op18 in its
PKA phosphorylated form show no detectable phenotype
on the level of MT morphology. These results are compat-
ible with a simple model where PKA promotes increased
tubulin polymerization by phosphorylation of Op18, which
switches off the MT-destabilizing activity of Op18.
 
The Role of Individual Phosphorylation Sites for
PKA-mediated Modulation of Op18 Activity
 
Previous studies have shown that both Ser-16 and Ser-63
are phosphorylated by PKA in vitro. This is in line with
the appearance of di-phosphorylated endogenous Op18 in
transfected cells induced to express a catalytic subunit of
PKA (Fig. 1 
 
B
 
). An earlier study has shown that overex-
pression of Op18 for 24 h results in hyper-phosphorylation
of Op18, mostly on Ser-38 (Marklund et al., 1996). This
phenomenon is most likely caused by Op18-induced MT
depolymerization, because it has been shown that drug-
induced depolymerization results in activation of a MAP
kinase-related kinase (Shinohara-Gotoh et al., 1991). In
the present study, we induced expression for a short time
period (4–5 h). This results in a more modest phosphoryla-
tion level of the overexpressed Op18-wt protein, as com-
pared to 24 h of induced expression, with 
 
z
 
20% of all
Op18 phosphorylated on a single site (Fig. 5). However, by
inducing expression of Op18-wt in the presence of PKA,
 
z
 
85% of all cellular Op18 is phosphorylated on one or
more sites (Fig. 5). Hence, unlike the situation of endoge-
nous Op18 in cells induced to express PKA alone (Fig. 1),
it is evident that not all ectopic Op18 molecules are phos-
phorylated on two sites in cells that also overexpress PKA.
To analyze the site-specificity of PKA-mediated phos-
phorylation of Op18, we determined the phosphorylation
status of a panel of phosphorylation site–deficient Op18
mutants co-expressed with either vector-Co or PKA (Fig.
5). Op18 can be phosphorylated on four specific sites in
K562 cells (Larsson et al., 1995). The Op18-S16,25,38,63A
derivative has all of these four sites mutated and the ex-
pressed protein is, as expected, essentially unphosphory-
lated if expressed together with PKA. It should be noted
that Op18 derivatives without epitope-tag were expressed
in this experiment, and the low level of phosphoisomers
observed for Op18-S16,25,38,63A is due to the endoge-
nous gene product. From the analysis shown in Fig. 5, it is
evident that Ser-63 is the predominant site phosphorylated
by PKA, because almost 75% of the Op18-S16,25,38A mu-
tant protein is phosphorylated on a single site. In contrast,
only 
 
z
 
30% of the Op18-S25,38,63A mutant protein is
phosphorylated on a single site.
To dissect the functional role of specific phosphoryla-
tion sites during PKA-mediated suppression of Op18 ac-
tivity, we determined cellular content of MT polymers in
cells co-transfected with PKA and the panel of kinase tar-
get site–deficient mutants of Op18 presented in Fig. 5. The
results in Fig. 6 show that phosphorylation of Ser-16/Ser-
63 is both sufficient and necessary for efficient PKA-medi-
ated suppression of Op18 activity (compare Op18-wt and
Op18-S25,38A). Single-site phosphorylation on Ser-63 only
results in a partial suppression of Op18 activity and single-
site phosphorylation of Ser-16 has even less effect (com-
pare Op18-S25,38,63A with Op18-S16,25,38A). Finally, and
as expected, PKA has no effect on the MT-destabilizing ac-
tivity of the Op18-S16,25,38,63A mutant protein.
In interpreting the result shown in Fig. 6, the stoichiom-
etry of phosphorylation shown in Fig. 5 should be consid-
Figure 3. Regulatory effects on the
MT system by conditional co-expres-
sion of PKA and Op18. K562 cells
were co-transfected with the indicated
pMEP4 derivatives (6 mg DNA of each
derivative) and transfected cell lines
were selected as in Fig. 1. Expression
was either suppressed with EDTA (2)
or induced with Cd21 (0.03 or 0.2 mM)
for 4 h. (A) Western blot analysis of
cells co-transfected with the indicated
pMEP4 constructs. The anti–c-myc an-
tibody was used for detection of PKA,
whereas Op18 was detected using rab-
bit anti-Op18:2–33. The minor shift in
mobility of both endogenous and ec-
topic Op18 protein after induction of
PKA is caused by phosphorylation.
Equal loading of total cell lysate was
confirmed by reprobing filters with
anti–triose-phosphate isomerase (not
shown). (B) Cellular content of MT
polymers of the co-transfected cells
treated as in A. The mean result of two
independent determinations is shown. 
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ered. Thus, only z30% of the overexpressed Op18-S25,
38,63A protein is phosphorylated on its remaining site,
Ser-16. Nevertheless, the results suggest that dual phos-
phorylation on Ser-16 and Ser-63 is of importance for effi-
cient PKA-mediated suppression of Op18 activity in intact
cells.
Kinetics of Dual Phosphorylation by PKA
PKA phosphorylates both Ser-16 and Ser-63 of Op18 in
intact cells, and both mono- and di-phosphorylated Op18
are generated (Fig. 5). To evaluate potential cooperativity
during PKA-mediated phosphorylation of Ser-16 and Ser-
63, the time course for generation of multi-phosphorylated
Op18 species in the presence of purified PKA was deter-
mined (Fig. 7 A). The data reveals transient accumulation
of mono-phosphorylated Op18 and subsequent accumula-
tion of di-phosphorylated Op18, until a time point where
Op18 is predominantly phosphorylated on two sites. Only
low levels of tri-phosphorylated Op18 are generated, which
indicates that Ser-16 and Ser-63 are the sole physiological
PKA target sites of Op18. Because .50% of the available
Op18 substrate is mono-phosphorylated at early time points,
before significant amounts of di-phosphorylated Op18 are
present, the data shows that Ser-16 and Ser-63 are not si-
multaneously phosphorylated by PKA.
To further address if Ser-16 and Ser-63 of Op18 are in-
dependently phosphorylated by PKA, the rate of in vitro
phosphorylation of the Op18-S63A and Op18-S16A mu-
tants was compared to that of Op18-wt. The results show
that Ser-63 is phosphorylated three- to fourfold faster than
Ser-16 (Fig. 7 B). Because the sum of the rates of phosphor-
ylation on each site (21 1 73 5 94 pmol PO4/min) is close to
the phosphorylation rate observed using the wild-type Op18
substrate (96 pmol PO4/min), the results suggest that Ser-
16 and Ser-63 are independently phosphorylated by PKA.
This, together with the site preference of PKA in vitro, is
in line with the distribution of Op18 phosphoisomers ob-
served in cells co-transfected with PKA and a panel of ki-
nase target site–deficient mutants (Fig. 5). Finally, native
gel analysis shows that extensive PKA-mediated phosphor-
ylation of an Op18-wt substrate, or the indicated mutated
substrates, results in essentially homogeneous prepara-
tions of specific Op18 phosphoisomers (Fig. 7 B).
Dissection of the Regulatory Role of Ser-16 and
Ser-63 Phosphorylation for Op18 Activities towards 
Purified Tubulin
Op18 has been shown to bind to tubulin, an interaction
that is likely to be of functional importance (Belmont and
Mitchison, 1996). To analyze the effect of Op18 phosphor-
ylation on tubulin binding, we used glutaraldehyde to pre-
serve Op18–tubulin complexes. As shown by SDS-PAGE
separation in Fig. 8 A, addition of glutaraldehyde pre-
serves an 83-kD complex that is recognized by antibodies
against Op18. As expected, this complex is also recognized
by anti–a-tubulin (data not shown). We have previously
reported that cross-linking with the zero-length cross-
linker 1-ethyl-3(3-[dimethylamino]propyl)carbodiimide, re-
Figure 4. Immunodetection of
MTs in co-transfected cells.
K562 cells co-transfected with
the indicated pMEP4 based con-
structs were induced with Cd21
(0.2 mM) for 4 h. Cells were
thereafter extracted with MT-
stabilizing buffer, fixed and dou-
ble stained with anti–a-tubulin
(green) and propidium iodide-
DNA (red). (A) MTs and DNA
staining of representative inter-
phase cells analyzed by epifluo-
rescence. (B) Flow cytometric
analysis of cellular MT content
of cells shown in A. Black lines
show control staining in the ab-
sence of anti–a–tubulin but in
the presence of fluorescein con-
jugated rabbit anti–mouse im-
munoglobulin. Blue lines depict
a-tubulin–specific fluorescence
of cells co-transfected with vec-
tor-Co and the pMEP4 con-
structs indicated above each panel.
Green lines depict a-tubulin–
specific fluorescence of cells co-
transfected with PKA and the
pMEP4 constructs indicated
above each panel.Gradin et al. PKA-mediated Regulation of the Microtubule System 137
sults in two distinct Op18–tubulin complexes migrating at
71 and 83 kD (Larsson et al., 1997). As shown in Fig. 8,
cross-linking with glutaraldehyde reproduces the 83-kD
but not the 71-kD complex. However, both protocols seem
to generate predominantly Op18 cross-linked to a-tubulin,
because the complexes react poorly with two different
anti–b-tubulin antibodies (Larsson et al., 1997; and data
not shown). It should be noted that cross-linking of Op18
to tubulin seems to be a very specific process, as nonre-
lated proteins do not interfere with the process, and Op18
is not cross-linked to tubulin that has been made polymer-
ization incompetent by 5 min at 608C (data not shown).
For functional dissection of individual phosphorylation
sites, Op18-S63A, Op18-S16A, and Op18-wt substrates
were phosphorylated to essentially complete stoichiome-
try by PKA (see native gel shown in Fig. 7 B). As shown in
Fig. 8 A, single-site phosphorylation on either Ser-16 or
Ser-63 results in a partial reduction of the Op18–tubulin
complex (z50%) as compared to the nonphosphorylated
Op18 protein. Moreover, and in agreement with our previ-
ous study (Larsson et al., 1997), phosphorylation on both
sites essentially abolished complex formation. Similar ef-
fects of mono- and diphosphorylation of Op18 on Ser-16/
Ser-63 were observed by using the 1-ethyl-3-[3-(dimeth-
ylamino)propyl]carbodiimide cross-linker (data not shown).
Hence, single-site phosphorylation on either Ser-16 or Ser-
63 have significant functional consequences on Op18–
tubulin complex formation but the effect of di-phosphory-
lation is clearly synergistic.
We also determined functional consequences of Ser-16
and Ser-63 phosphorylation of Op18 during MT polymer-
ization. The assay was performed in the presence of taxol
and the activity of Op18 is, therefore, likely to reflect in-
hibition of polymerization rather than destabilization of
MTs. As shown in Fig. 8 B, unphosphorylated Op18 com-
pletely inhibits MT polymerization at z4 mM concentra-
tion, whereas dual phosphorylation on Ser-16 and Ser-63
neutralizes the inhibitory activity of Op18. The effect of
single-site phosphorylation of either Ser-16 or Ser-63 alone
was small and barely detectable in this assay system. Taken
together, dual phosphorylation on Ser-16 and Ser-63 blocks
both tubulin complex formation and the inhibitory activity
during MT polymerization, whereas the effect of single-
site phosphorylation could only be detected with certainty
by analyzing tubulin complex formation.
Discussion
By using a conditional expression strategy, we show that
the catalytic subunit of PKA mediates a rapid and dra-
matic increase in cellular MT-polymer content in parallel
with dual phosphorylation and partial degradation of Op18.
PKA is a multi-functional kinase with a multitude of cyto-
solic and nuclear protein substrates. To evaluate a poten-
tial role of Op18 phosphorylation for PKA regulation of
the MT system, a panel of kinase-target–deficient mutants
of Op18 were co-transfected with PKA. The result demon-
strated that PKA switches off the MT-destabilizing activ-
ity of Op18 in intact cells by dual phosphorylation of Ser-
16/Ser-63. In vitro studies confirmed the importance of dual
phosphorylation of these two sites in switching off Op18
activity. Hence, the model system used in this study dem-
onstrated the potential of PKA to regulate the MT system
via Op18 phosphorylation.
Immunofluorescence analyses suggest that PKA expres-
sion induces a homogeneous increase of cellular content of
MT polymers without gross alterations in MT morphol-
ogy. Moreover, cells overexpressing Op18-wt together with
PKA show no detectable phenotype on the level of MT
morphology (Fig. 4). Hence, it appears that Op18 in its
PKA-phosphorylated form is devoid of all of its MT-regu-
latory properties. These results are compatible with a sim-
ple model where PKA promotes increased tubulin poly-
merization by phosphorylation of Op18, which in turn
directly switches off the MT-destabilizing activity of Op18.
This study demonstrates that dual phosphorylation of
Ser-16 and Ser-63 inactivates both tubulin-binding activity
and MT polymerization inhibitory activity of Op18. This
may appear contradictory to a recent study (Horwitz et al.,
1997), in which the potential mimic of phosphorylation
provided by Asp substitutions at phosphorylated sites was
analyzed. In this study the authors concluded that specific
Asp substitutions decreased the MT-destabilizing activity
of a panel of glutathione S-transferase–Op18 fusion pro-
tein derivatives as analyzed by micro-injection of a cell line.
Figure 5. Distribution of Op18 phosphoisomers in cells induced
to express a panel of kinase target site–deficient mutants of Op18
together with PKA. K562 cells co-transfected with either vector
Co (top) or PKA (bottom) and the indicated pMEP4 derivatives
of Op18 were induced with Cd21 (0.2 mM) for 4 h. Phosphoiso-
mers of Op18 were analyzed by a native PAGE system as in Fig.
1 and phosphorimager analysis of radioactive bands was used for
quantification. It should be noted that the Op18 derivatives used
in this experiment do not contain the Flag epitope-tag. The
present co-transfection protocol results in Op18 derivatives ex-
pressed at 5–10-fold higher levels than the endogenous Op18 pro-
tein. Hence, the data primarily reflects the phosphorylation status
of the recombinant Op18 gene product, but phosphorylation of
endogenous Op18 is still notable.The Journal of Cell Biology, Volume 140, 1998 138
However, in vitro assays failed to reveal any effect by Asp
substitutions on the MT polymerization inhibitory activity
of the Op18 fusion proteins. To explain these results, the
authors proposed that cellular factors are required to re-
veal the inhibitory effect of Op18 phosphorylations. Be-
cause our studies show that phosphorylation on specific
sites of the native Op18 protein clearly inhibits its in vitro
activity, it appears that Asp substitutions at phosphoryla-
tion sites of a fusion protein only partially mimic the regu-
latory effects of phosphorylation.
As outlined in the introduction section, Op18 has been
independently identified by several groups. In at least
three cases, Op18 was initially identified as a major phos-
phorylation event in response to increased cAMP levels,
induced by either specific hormones or drugs (Brattin and
Portanova, 1981; Schubart, 1982; Sobel and Tashjian, 1983).
This together with in vitro phosphorylation studies, and
site-specific phosphorylation of Op18 in response to ec-
topic PKA expression shown herein, suggest that Op18 is a
physiological substrate for PKA. However, Op18 is not
phosphorylated in response to PKA activation in all cell
types investigated. Hence, published results suggest that,
whereas Op18 is clearly a likely major cytosolic substrate
for PKA in cell types of neural origin, Op18 phosphoryla-
tion is not significantly increased in response to cAMP-
linked agonists in hematopoietic/lymphoid cell types (Mary
et al., 1989; Strahler et al., 1992). The reason for these dif-
ferences is not clear, but it seems possible that PKA activ-
ity is less abundant in some cell types, and/or that most of
the catalytic subunits are translocated to the nucleus upon
activation. Nevertheless, Op18 is clearly efficiently phos-
phorylated in response to cAMP signaling in many cell
types, which the present study predicts has implications for
regulation of the MT system.
PKA has previously been implicated in the regulation of
the MT systems. For example, the two neuronal MAPs,
MAP2 and tau, are phosphorylated on the same sites in in-
tact cells in response to cAMP-linked agonists as they are
by PKA in vitro (Jefferson and Schulman, 1991; Fleming
and Johnson, 1995). It is generally believed that different
signal transduction cascades may control MT dynamics by
phosphorylation of MAPs. In functional studies, phosphor-
ylation has been shown to inhibit to various extents the
MT-stabilizing in vitro activity of MAPs (Jameson and Cap-
low, 1981; Lindwall and Cole, 1984; Drechsel et al., 1992;
Hoshi et al., 1992; Masson and Kreis, 1995; Ookata et al.,
1995; Trinczek et al., 1995). Hence, from these studies it
can be predicted that phosphorylation of MAPs in intact
cells should result in clearly visible disruption of MTs. Al-
though many studies have been concerned with phosphor-
ylation of MAPs by PKA, there is to our knowledge no
study demonstrating PKA-mediated disruption of MTs in
intact cells.
If, as outlined above, PKA modulates the MT system by
phosphorylation of MAPs, previous studies predict that
activation of the kinase should destabilize MTs. Using a
conditional overexpression strategy, the present study shows
the opposite result, namely, that PKA activity mediates an
increase in cellular MT polymer content. Moreover, PKA
can efficiently switch off the potent MT-destabilizing ac-
tivity of Op18 in intact cells, provided that the Ser-16 and
Ser-63 Op18 target sites are intact, suggesting an Op18-
dependent mechanism. Another indication that PKA reg-
ulation of MTs is primarily mediated by Op18 in K562
Figure 6. Dual phosphorylation of Ser-16
and Ser-63 is both sufficient and neces-
sary for efficient PKA-mediated mod-
ulation of the MT-destabilizing activity
of Op18. K562 cells were co-transfected
with the indicated pMEP4 derivatives
(6 mg DNA of each derivative). Ex-
pression was either suppressed with
EDTA (2) or induced with Cd21 (0.03
or 0.2 mM) for 4 h. (A) Western blot
analysis of cells co-transfected with the
indicated pMEP4 constructs. The anti–
c-myc antibody was used for detection
of PKA and Op18 was detected by rab-
bit anti-Op18:34–149. The Op18 deriv-
atives used in this experiment do not
contain the Flag epitope tag and, con-
sequently, co-migrates with endoge-
nous Op18. (B) Cellular content of MT
polymers of the co-transfected cells
treated as in A. The mean result of two
independent determinations is shown.Gradin et al. PKA-mediated Regulation of the Microtubule System 139
cells comes from the observation that specific Op18 mu-
tants can completely abolish the MT-stabilizing effect of
PKA. If PKA activation would mediate increased MT
polymers primarily by activating MT-stabilizing proteins
(e.g., MAPs), it would be anticipated that the resulting
MTs would show increased stability, and therefore be par-
tially resistant to the destabilizing activity of specific mu-
tants of Op18. Co-transfection experiments show that this
is not the case because PKA expression is without any ef-
fect on the MT system in the presence of the Op18-mu-
tants with Ser-16 and Ser-63 to Ala substitutions (Figs. 3
and 6). However, although Op18 appears to be a major
regulator of the MT system in the K562 erythroleukemia
cell line, this does not need to be the case in all tissues/cell
lines. It is also possible that other phosphorylation respon-
sive proteins, functionally related to Op18, are involved in
regulation of the interphase MT network. If this is the
case, redundancy may explain why mice with both alleles
of the Op18 gene disrupted by homologous recombination
survive and show normal development (Schubart et al.,
1996).
The MT system seems, in general, less intimately associ-
ated with second messenger systems than is the actin sys-
tem, and little is known about its regulation in response to
external signals (Mitchison, 1992). However, the present
and a previous study by us show that the recently identi-
fied MT-regulating protein, Op18, links the MT system and
at least two second messengers, namely cAMP and Ca21.
In our previous study, a constitutively active mutant of
CaMK IV/Gr was shown to suppress the MT-destabilizing
activity of Op18-wt by phosphorylating Ser-16 (Melander
Gradin et al., 1997). However, the importance of constitu-
tive phosphorylations on additional sites for suppression
of Op18 activity was not addressed. Thus, overexpressed
Op18 shows significant levels of constitutive phosphoryla-
tion on Ser-38, which is likely to have a synergistic effect
together with CaMK IV/Gr-mediated Ser-16 phosphoryla-
tion (Larsson et al., 1997). In the present study, the MT-
regulatory role of all four potential phosphorylation sites
of Op18 was determined in response to induced expres-
sion of PKA. The result shows that PKA phosphorylates
both Ser-16 and Ser-63 in intact cells, with preference for
the latter site. Moreover, it was also demonstrated that
PKA-mediated dual phosphorylation of Op18 on these
two Ser residues is both necessary and sufficient for effi-
cient regulation of the MT system. As predicted from the
dual specificity of PKA, comparison in the same experi-
ment reveals that PKA is more potent than CaMK IV/Gr
in inducing increase in cellular content of MT polymers
(Fig. 1). Furthermore, the importance of dual phosphory-
lation of Op18 was also evident in co-transfection experi-
ments in which Op18 was overexpressed. Hence, although
CaMK IV/Gr mediates complete phosphorylation on Ser-16
of overexpressed Op18, the resulting MT-destabilizing ac-
tivity of Op18-wt was not as efficiently suppressed as ob-
served in this study by co-transfection of PKA (Fig. 3).
This is despite the observation that ectopic PKA did not
mediate complete phosphorylation of its two target sites of
Op18, as indicated by quantification of Op18 phosphoiso-
mers (Fig 5). Because the kinase activity of ectopic PKA
was not sufficient to dual phosphorylate overexpressed
Op18 to completion, the data does not provide any infor-
mation on the relative MT-regulatory importance of Ser-
16 versus Ser-63 in intact cells (Figs. 5 and 6). However, in
vitro experiments suggested similar effects of phosphory-
lation of either of the two Ser residues and a clear-cut syn-
ergistic effect of phosphorylating both sites (Fig. 8).
The effects of phosphatase/kinase inhibitors on MT dy-
namic instability was recently investigated in living newt
lung epithelial cells (Howell et al., 1997). Significant and
rapid (within 1 min) alterations of the dynamic behavior of
individual MTs was observed in response to all inhibitors
tested. The authors proposed that both MAPs and Op18
are likely mediators of the MT-regulatory response to drug-
induced alterations of protein phosphorylation. Moreover,
a previous report has also shown that phorbol ester treat-
ment of macrophages results in a rapid (detectable within
minutes) increase in MT length and number (Robinson
and Vandre, 1995). Phorbol esters are specific activators
of protein kinase C, which is an upstream activator of the
MAP kinase in leukocytes (Cantrell, 1994). Because Op18
is a major cytosolic substrate of the MAP kinase (Marklund
et al., 1993b), it seems possible that the reported effect is
at least in part due to phosphorylation-mediated inactiva-
tion of Op18. In addition, studies on murine embryological
fibroblasts have shown that stimulation with thrombin,
Figure 7. PKA-mediated in vitro phos-
phorylation of Op18. (A) Op18-wt was
mixed with PKA (2.8 U of kinase per
mg Op18) using the conditions de-
scribed in Materials and Methods. Spe-
cific Op18 phosphoisomers were there-
after quantitated at the indicated time
points by separation on a native gel
system. Mono- (d), di- (m), and tri-
(j) phosphorylated Op18 isomers are
shown. (B) Op18-wt and the indicated
kinase target site–deficient mutants of
Op18 were in vitro phosphorylated by
PKA as above. Op18 phosphoisomers
were thereafter analyzed by native gels
together with nonphosphorylated
Op18. After transfer to nitrocellulose filter, Op18 phosphoisomers were revealed by rabbit anti-Op18 and 125I-protein A followed by au-
toradiography. The rate of PO4 incorporation of the indicated Op18 derivatives is presented below the autoradiograph.The Journal of Cell Biology, Volume 140, 1998 140
epidermal growth factor, and phorbol esters increases the
cellular content of MT polymers (Ball et al., 1992). Be-
cause Op18 is likely to be phosphorylated in response to
all of these three mitogens, it seems possible also in these
cases that inactivation of Op18 contributes to increased
MT polymers.
One potential mechanism for increased cellular content
of MT polymers in response to external signals may be
stimulation of tubulin synthesis. In the studies on mac-
rophages and fibroblasts, mentioned above, changes in the
total pool of tubulin were not quantified. However, be-
cause both studies reported significant responses within an
hour after stimulation, it seems unlikely that an increase in
the total pool of tubulin is responsible for the observed in-
crease of cellular MT polymers. In the present study, alter-
ations of MT polymers in response to overexpressed PKA,
which was detected within 2 h (Fig. 2), was determined by
quantification of both polymerized and soluble tubulin.
Over a time course of 12 h we did not observe any detect-
able alteration in the total pool of tubulin by overexpress-
ing PKA or Op18 (data not shown). Hence, in the present
study, and most likely in the two studies mentioned above,
external signals appear to induce an early increase in MT
polymers in the absence of alterations of the tubulin pool
size. In a longer time perspective, however, the rate of tu-
bulin synthesis is most likely changed because the level of
tubulin heterodimers is regulated by an autoregulatory
mechanism, that is related to the pool size of unpolymer-
ized tubulin heterodimers (Cleveland et al., 1981; Pachter
et al., 1987).
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